Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-137545

Chief R&D Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zalevsky Jonathan · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-13 Grant or award : show line 1 in the form +135,000 378,019 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-12-13 Grant or award : show line 2 in the form Stock Option +270,000 270,000 D
2024-12-13 Grant or award : show line 3 in the form Stock Option +375,000 375,000 D
Loading xslF345X05/ownership.xml…